The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

Please provide your email address to receive an email when new articles are posted on . “We know that UTIs are one of the most common infections leading to hospitalization, and recurrent UTIs are ...

For Trade and Medical Media OnlyEnrolment completed in Phase III ReSPECT study in prophylaxis of fungal infections in adult patients undergoing allogeneic blood and marrow transplantTopline results ...

"We know definitively that we can prevent almost all bleeding – decreasing bleeding frequency by > 90% as well as the severity of bleeding episodes – by continuing prophylaxis into adulthood or ...

WOBURN, Mass.--(BUSINESS WIRE)--ROMEG Therapeutics, an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today announced that the U.S.